Press Releases

15 Nov 2012

bioMérieux and Quanterix Sign Strategic Partnership in Ultrasensitive and Multiplex Immunoassays

Quanterix’s Simoa™ technology to be developed for diagnostic applications. bioMérieux gains exclusive rights for clinical laboratories and industrial applications. bioMérieux takes equity stake in Qua...

07 Nov 2012

VIDAS® 3, the New-generation VIDAS®

VIDAS® 3, the New-generation VIDAS® Presented at the JIB International Biologists Congress...

31 Oct 2012

Dr. Mark Miller joins bioMérieux as Chief Medical Officer

World-leading expert on infectious disease prevention and control to enhance medical value of bioMérieux’s solutions...

23 Oct 2012

bioMérieux - Business Review for the nine months ended September 30, 2012

Sales Up 7.5% at constant exchange rates Of which 3.2%* organic growth Confirmed strong momentum in emerging markets 28% of consolidated sales 17%* organic growth...

09 Oct 2012